VitaDAO
Tackling aging with the power of a global community and radically extend healthy human lifespan by funding cutting-edge aging research and democratizing ownership of Intellectual Property.
By 2050, a doubled global 60+ population (2B) drives a ~$100B longevity market, incentivizing research to reduce disease burden and healthcare costs.
900M to ~2B
Global 60+ population to double by 2050
$100B
Longevity therapeutics market by 2030
$1T +
Healthcare costs for aging diseases
Project
Additional Documentation
Longevity research is an interdisciplinary field dedicated to understanding and slowing the biological mechanisms of aging, ultimately aiming to extend healthy human lifespans. The problem space spans a massive and urgent need: as populations age, age-related diseases—from neurodegenerative disorders like Alzheimer’s to metabolic and cardiovascular conditions—are set to overwhelm healthcare systems and create severe economic burdens. Addressing these challenges calls for innovative funding structures and collaborative models. VitaDAO implements a decentralized approach, using blockchain-based governance to pool resources and support diverse, early-stage research initiatives. By distributing decision-making and funding power among a global community of scientists, investors, and advocates, such decentralized platforms help accelerate discoveries, improve access to cutting-edge treatments, and ensure that longevity research progresses with greater transparency, inclusivity, and efficiency.
Additional Documentation
Longevity research is an interdisciplinary field dedicated to understanding and slowing the biological mechanisms of aging, ultimately aiming to extend healthy human lifespans. The problem space spans a massive and urgent need: as populations age, age-related diseases—from neurodegenerative disorders like Alzheimer’s to metabolic and cardiovascular conditions—are set to overwhelm healthcare systems and create severe economic burdens. Addressing these challenges calls for innovative funding structures and collaborative models. VitaDAO implements a decentralized approach, using blockchain-based governance to pool resources and support diverse, early-stage research initiatives. By distributing decision-making and funding power among a global community of scientists, investors, and advocates, such decentralized platforms help accelerate discoveries, improve access to cutting-edge treatments, and ensure that longevity research progresses with greater transparency, inclusivity, and efficiency.
Paolo Binetti
Paolo is laser focused on advancing longevity biotech. He has been a core contributor of VitaDAO for over 2 years, covering all aspects of dealflow, from sourcing to incubation, due diligence, terms negotiation, deal closure, and portfolio management. He brings 20 years of experience in business development, project management, and R&D.
Updates
Stay up to date
Get the latest community updates and find out about upcoming VitaDAO developments
